Replies to post #45354 on Breakthrough Chemistry Inc (BKTH)

[I ll be back]

I've wondered the same thing.

One would have to think that the Kane & McHenry guys anticipate big upside in the PFD class BKTH shares they are getting in this deal.

However, I also have to wonder if it doesn't relate to the 2023 PR under the terms of the $5M in sales over 5-years. Given they are roughly half way through the contract and given the lack of sales related to BKTH in that time, I have to wonder if Cellhelmet didn't see a value play in selling the company as opposed to a default. Given we know have a good idea who the vendor was in 2023, and given their line of products versus documented sales, we know they likely didn't even come close to reaching the required volume. Just a thought.